Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hematoporphyrin ether photodynamic therapy in severe esophageal obstruction due to esophageal cancer
CTR20161063Phase 3Active
- Sponsor
- Zhongxing Yangfan
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hematoporphyrin ether in esophageal cancer, sponsored by Zhongxing Yangfan. Started Feb 2017; status: active.
02
Drugs
hematoporphyrin ether
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on CTR20161063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20161063.